台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP062: Elucidation of the therapeutic role of nuclear respiratory factor-1 in the regulation of prostate cancer

2019-07-07 • 觀看: 1498 • 回應: 0 • doc
MP061: The relationship of prostate health index (PHI) and PSA based on the age group in CMUH experience

2019-07-07 • 觀看: 1662 • 回應: 0 • doc
MP060: Outcome of lymph node dissection in renal pelvis urothelial carcinoma

2019-07-07 • 觀看: 1809 • 回應: 0 • doc
MP059: The clinical significance of tumor size and preoperative systemic immune-inflammation index (SII) in oncologic outcomes in patients with upper tract urothelial carcinomas (UTUC)

2019-07-07 • 觀看: 1568 • 回應: 0 • doc
MP058: Gold nanoparticle as photosensitizing agent in photodynamic therapy targeting bladder cancer

2019-07-07 • 觀看: 1787 • 回應: 0 • doc
MP057: Elucidation of the therapeutic role of osmanthus fragrans active compound in the regulation of prostate cancer

2019-07-07 • 觀看: 2034 • 回應: 0 • doc
MP056: Prognostic factors for patients with de novo metastatic renal cell carcinoma receiving cytoreductive nephrectomy followed with target therapy: who will really benefit from the cytoreductive nephrectomy?

2019-07-07 • 觀看: 1641 • 回應: 0 • doc
MP055: Clinicopathologic analysis of epithelioid renal angiomyolipoma: a single institute experience of consecutively excised 23 cases

2019-07-07 • 觀看: 1770 • 回應: 0 • doc
MP054: Tumor contact surface area predict the non-tumor renal volume after partial nephrectomy

2019-07-07 • 觀看: 1755 • 回應: 0 • doc
MP053: Renal cell carcinoma T3 stages subgroup survival analysis - a retrospective single-institution study

2019-07-07 • 觀看: 1618 • 回應: 0 • doc
MP052: MicroRNA-145 regulates invasion in upper tract urothelial carcinoma by targeting ARF6

2019-07-07 • 觀看: 1595 • 回應: 0 • doc
MP051: Hormone-secreting adrenocortical carcinoma: a case report

2019-07-07 • 觀看: 1510 • 回應: 0 • doc

Prev
813
814
815
816
817
818
819
820
821
822
Next
/ 1134